diabetesLife After Avandia: New Diabetes Drugs Will Face Tougher Testing for Heart-Failure Risks
In the wake of widespread reports of heart failures, liver damage, and other patient injuries and seemingly non-stop controversy surrounding the top-selling type-2 diabetes drug Avandia, the Food and Drug Administration now says that future diabetes drugs will face much tougher scrutiny.
Pancreatic Disease Risk Increased by Type 2 Diabetes Drug Byetta
Byetta, a drug commonly prescribed for the treatment of type 2 (adult onset) diabetes, has been linked to an increased risk of deadly pancreatic disease. Dozens of Byetta patients have suffered a painful injury called hemorrhagic pancreatitis, or inflammation of the pancreas, that resulted in death or serious injuries. The Food and Drug Administration has issued several public advisories about Byetta’s connection to pancreatic disease and warned users about the risk.
Antipsychotic Seroquel Linked to Increased Risk of Diabetes, Other Blood Sugar Disorders
Seroquel, the antipsychotic drug made by AstraZeneca and widely used to treat schizophrenia and bipolar disorders, has been shown to increase the risk of developing diabetes and other blood sugar disorders. First approved by the Food and Drug Administration in 1997, Seroquel is among a newer class of medications called atypical antipsychotics, which are billed as being just as effective as older antipsychotics with fewer side effects. However, older antipsychotic drugs such as Haldol do not carry the same of …
Avandia: Popular Diabetes Drug Linked to Fatal Heart Attacks
Avandia, the blockbuster type 2 diabetes drug taken by an estimated six million Americans, has been linked to an increased risk of heart attack and cardiovascular death. Avandia was approved in 1999 for the treatment of type 2, or adult onset, diabetes, which affects an estimated 18 to 20 million Americans and is a leading cause of coronary heart disease, blindness, kidney failure, and limb amputation. Diabetes occurs when the body either does not produce enough insulin or is insensitive …
facebook
rss
twitter